Irinotecan

Irinotecan is a chemotherapy drug that has as active substance Irinotecan Hydrochloride.

It is an injectable drug, used exclusively by adults and directed to the elimination of cancerous cells of the body.

Irinotecan Indications

Cancer in the colon; cancer in the rectum; lung cancer; ovarian cancer; breast cancer.

Side effects of Irinotecan

Increased sweating; diarrhea; saliva production; stomach pain; nausea; vomiting; loss of appetite; low resistance to infections; anemia; loss of hair; tiredness; weakness; watery eyes.

Contraindications of Irinotecan

Pregnant women; women in the lactation phase; individuals with hypersensitivity to components of the Irinotecan formula.

How to use Irinotecan

Injectable Use

Adults

The dose administered is usually 180 mg Irinotecan every 2 weeks, which dose can be adjusted by the physician according to the age, clinical status and side effects manifested by the patient.

The medicine is applied to the vein for 30 to 90 minutes.